CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $36.25M, above the global median of $18.92M
- PositionP/E ratio is 12.15×, lower than 95% of its Medical Instruments & Supplies peers (median 28.57×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.53%
Annual Rate
JPY 44.00Paid annual
Payout Ratio
30.7%Sustainable
Next Ex-Dividend
Dec 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
62.55BJPY398.73M · vs all stocks (USD)
Trailing P/E
12.15xvs Medical Instruments & Supplies peers
Revenue (TTM)
69.49BJPY442.97M · vs all stocks (USD)
Profit Margin
6.47%vs Medical Instruments & Supplies peers
52-Week Change
-38.13%vs all stocks
Market Capitalization
62.55BJPY398.73M · vs all stocks (USD)
Enterprise Value
58.67BJPY374.04M · vs all stocks (USD)
Trailing P/E
12.15xvs Medical Instruments & Supplies peers
Forward P/E
8.40xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.7684xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.93xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.8440xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
6.18xvs Medical Instruments & Supplies peers
Profit Margin
6.47%vs Medical Instruments & Supplies peers
Operating Margin
11.20%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
9.23%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
17.29%vs Medical Instruments & Supplies peers
Revenue (TTM)
69.49BJPY442.97M · vs all stocks (USD)
Revenue per Share (TTM)
2.27KJPYUpdated Sep 20, 2026Quarterly Revenue Growth
80.60%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
50.71BJPY323.26M · vs all stocks (USD)
EBITDA (TTM)
7.16BJPY45.64M · vs all stocks (USD)
Net Income (TTM)
4.50BJPY28.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
23.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
7.58BJPY48.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.69BJPY36.25M · vs all stocks (USD)
Trailing Annual Dividend Rate
44.00JPYUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.53%vs all stocks
Payout Ratio
30.70%vs Medical Instruments & Supplies peers
Revenue
50.15BJPYFY2025 · Dec 31, 2025Cost of Goods Sold
11.68BJPYFY2025 · Dec 31, 2025Gross Profit
38.47BJPYFY2025 · Dec 31, 2025Operating Income
5.99BJPY38.19M · vs all stocks (USD)
Pre-tax Income
5.92BJPYFY2025 · Dec 31, 2025Income Tax Expense
1.80BJPYFY2025 · Dec 31, 2025Net Income
4.12BJPYFY2025 · Dec 31, 2025EBIT
6.01BJPYFY2025 · Dec 31, 2025EBITDA (Income Statement)
7.16BJPYFY2025 · Dec 31, 2025Non-operating Interest Income
75.00MJPYFY2025 · Dec 31, 2025Non-operating Interest Expense
85.00MJPYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00JPYFY2025 · Dec 31, 2025Operating Cash Flow
5.57BJPYFY2025 · Dec 31, 2025Free Cash Flow
3.65BJPYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
10.06BJPYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
5.92BJPYFY2025 · Dec 31, 2025Other Non-cash Items
-27.00MJPYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-277.00MJPYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-48.00MJPYFY2025 · Dec 31, 2025Capital Expenditures
-1.93BJPYFY2025 · Dec 31, 2025Net Intangibles (CF)
-347.00MJPYFY2025 · Dec 31, 2025Net Acquisitions
-16.17BJPYFY2025 · Dec 31, 2025Purchase of Investments
-5.50BJPYFY2025 · Dec 31, 2025Sale of Investments
5.50BJPYFY2025 · Dec 31, 2025Other Investing Activity
-625.00MJPYFY2025 · Dec 31, 2025Net Investing Cash Flow
-18.72BJPYFY2025 · Dec 31, 2025Long-term Debt Payments
0.00JPYFY2025 · Dec 31, 2025Net Short-term Debt Issuance
15.10BJPYFY2025 · Dec 31, 2025Common Dividends Paid
-1.23BJPYFY2025 · Dec 31, 2025Other Financing Charges
-2.00MJPYFY2025 · Dec 31, 2025Net Financing Cash Flow
13.87BJPYFY2025 · Dec 31, 2025Shares Outstanding
30.66MSharesUpdated Sep 20, 2026Float Shares
18.89MSharesUpdated Sep 20, 2026% Held by Insiders
57.06%vs all stocks
% Held by Institutions
32.67%vs all stocks
Total Cash (MRQ)
12.93BJPY82.40M · vs all stocks (USD)
Total Cash per Share (MRQ)
421.48JPYUpdated Sep 20, 2026Total Debt (MRQ)
18.21BJPY116.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6577xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.04xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
902.72JPYUpdated Sep 20, 2026Total Assets
62.95BJPY401.31M · vs all stocks (USD)
Total Current Assets
25.05BJPYFY2025 · Dec 31, 2025Total Liabilities
36.99BJPYFY2025 · Dec 31, 2025Total Non-current Assets
37.90BJPYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.38BJPYFY2025 · Dec 31, 2025Total Current Liabilities
34.61BJPYFY2025 · Dec 31, 2025Cash & Cash Equivalents
10.06BJPYFY2025 · Dec 31, 2025Accounts Receivable
3.07BJPYFY2025 · Dec 31, 2025Inventory
7.17BJPYFY2025 · Dec 31, 2025Accounts Payable
3.05BJPYFY2025 · Dec 31, 2025Short-term Debt
18.27BJPYFY2025 · Dec 31, 2025Other Current Liabilities
886.00MJPYFY2025 · Dec 31, 2025Long-term Debt
599.00MJPYFY2025 · Dec 31, 2025Other Non-current Liabilities
273.00MJPYFY2025 · Dec 31, 2025Common Stock (Book)
220.00MJPYFY2025 · Dec 31, 2025Retained Earnings
15.37BJPYFY2025 · Dec 31, 2025Total Shareholders' Equity
25.96BJPY165.52M · vs all stocks (USD)
52-Week Low
1.64KJPYUpdated Sep 20, 202652-Week High
2.92KJPYUpdated Sep 20, 202652-Week Change
-38.13%vs all stocks
50-Day MA
1.85KJPYUpdated Sep 20, 2026200-Day MA
1.95KJPYUpdated Sep 20, 2026Avg 10-Day Volume
203.99KSharesUpdated Sep 20, 2026Avg 30-Day Volume
251.28KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
143.28JPYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 12.15×, lower than 95% of its Medical Instruments & Supplies peers (median 28.57×)Notable
P/E ratio: 12.15Industry median: 28.57Industry P5: 12.86Peers compared: 59.00
Financial Health
Altman Z-Score 2.29: grey zoneSignificant
Altman Z-Score: 2.29
High earnings qualityNotable
Earnings Quality Score: 1.03
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $36.25M, above the global median of $18.92MNotable
Levered free cash flow (USD): 36,254,056.708Global Median: 18,920,810.7
Companies that share the same coordination system — how they create, deliver, or capture value.
Arbonia AG
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Carthane Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
RattanIndia Power Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shandong Yabo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Myriad Genetics Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ibstock plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Deceuninck NV
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kitazato Corporation
Tier 1ProductionThroughput-Bound ConversionRule
Shandong NewJiFeng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Slavneft-Yaroslavnefteorgsintez Joint Stock Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Edan Instruments Inc.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Yamaichi Electronics Co., Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Guangdong Silver Age Sci & Tech Co. Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated